Resona Asset Management Co. Ltd. Makes New Investment in Humana Inc. (NYSE:HUM)

Resona Asset Management Co. Ltd. bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 39,837 shares of the insurance provider's stock, valued at approximately $10,117,000.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of Humana by 15.8% during the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares during the period. Pzena Investment Management LLC boosted its position in Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after acquiring an additional 1,103,132 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after acquiring an additional 63,562 shares in the last quarter. Norges Bank acquired a new stake in shares of Humana in the fourth quarter valued at approximately $416,202,000. Finally, Boston Partners lifted its position in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after purchasing an additional 893,637 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. Truist Financial lifted their price objective on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research report on Friday. Guggenheim initiated coverage on shares of Humana in a report on Wednesday. They issued a "buy" rating and a $326.00 target price on the stock. Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Finally, Mizuho upped their price objective on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a research note on Wednesday. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $286.00.

Remove Ads

Humana Price Performance

Shares of NYSE HUM traded up $1.75 during midday trading on Friday, reaching $292.00. The company's stock had a trading volume of 515,615 shares, compared to its average volume of 1,743,701. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market cap of $35.24 billion, a P/E ratio of 29.27, a P/E/G ratio of 2.05 and a beta of 0.62. The business's 50 day moving average price is $265.56 and its two-hundred day moving average price is $270.77. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.21%. Humana's dividend payout ratio (DPR) is 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.